quibim precision powering ai and imaging...
Post on 18-Mar-2020
2 Views
Preview:
TRANSCRIPT
Quantitative Imaging Biomarkers in Medicine
www.quibim.com
@Quibimbiomarker
QUIBIM PRECISION
Powering AI and Imaging Biomarkers
1896. William Morton
First radiology report: Abdomen X-Ray
“… there is no stone of appreciable size in
the kidney…”
2018
Today radiology report: CT renal stones
“… no adenopathy is seen.”
DISEASE vs. THE EYE
THE NEED:MEASUREMENTS
“When you can measure what you are
speaking about, and express it in
numbers, you know something about it”
Lord Kelvin
Imaging BiomarkersIt is a measurement obtained objectively from medical images which represents and quantifies a tissue property
(structural, functional or biological) extracted after applying computational models to images and specific signal
processing, resolved in space and time.
to measure is to know
QUIBIM PRECISION®
platform
ONCOLOGYSolid tumours, hematology
Diffusion (IVIM, DKI),
Pharmacokinetics, Bone
Marrow Infiltration, Multi-
Parametric Analysis
BONEOsteoporosis
Trabecular morphology,
fractal irregularity,
anisotropy, mechanical
resistance & elasticity
LUNGCOPD
Lung & lobes volumes,
emphysema percentage,
bronchia wall, trachea wall
NEUROAlzheimer, ALS, MS, Stroke
Volumetry, cortical thickness,
lesions segmentation, iron
quantification, tractography
LIVERSteatohepatitis, fibrosis,
hemochromatosis
Fat fraction quantification,
iron concentration, Diffusion-
IVIM
IMAGING BIOMARKERS DEVELOPMENT
Value
Proof of concept Proof of mechanism Image acquisition Image processing Image analysis
Measurements Proof of principleProof of efficacy
and effectivenessStructured report
Idea
Martí-Bonmati ́ L, Alberich-Bayarri A, et al. Imaging biomarkers, quantitative imaging, and bioengineering. Radiologia. 2012;54:269-278.
ESR statement on the stepwise development of imaging biomarkers. Insights Imaging (2013) 4:147–152.
Our stepwise methodology was
adopted in 2013 by the European
Society of Radiology guidelines
IMAGING BIOMARKERS DEVELOPMENT
SCIENTIFIC EXCELLENCE
1ST IMAGING BIOMARKERS Book
Editors: QUIBIM Founders
Examines all aspects of the development of
imaging biomarkers and their integration into
clinical practice
TARGET MARKETS
Innovative Medical Doctors and
Researchers
Boost your imaging workflows!
We act in the full process of imaging biomarkers
integration, from the optimization of the images
acquisition in the equipments up to the biomarkers
report integration into the PACS.
Step-up your clinical trials!
We can safely detect and monitor early biological
changes in the organs and tissues as a
consequence of a given therapy.
CRO’s and Biotech Companies
QUIBIM Care QUIBIM Pharma
BUSINESS MODELS
Local
Basic license + modules 1st year
yearly manteinance
Cloud
Pay per analysis
Customized versions
From Images to Data
QUIBIM Precision® Platform
Our Advanced Cloud Platform for centralized image
management, storage and quantitative analysis.
QUIBIM Precision® platform
• Web
application/non-
installation required.
• Accesible from any
computer with
internet.
• Includes Quantitative
Analysis Plugins.
• Upload your image studies just with a ‘Drag&Drop’ action on
your DICOM files!
• Pre-visualization DICOM viewer
QUIBIM Precision® platform
• The Platform includes a Cloud DICOM Viewer with ROI &
Segmentation tools.
QUIBIM Precision® platform
• The platform includes automatic imaging biomarkers tools for
different pathologies in: Brain, Musculoskeletal, Oncology, Liver and
Lung.
• DataMiner Module
QUIBIM Precision® platform
All the raw data and variables are downloadable by the customer in a wide
range of formats: XLS, SPSS, CSV, MATLAB
STRUCTURED REPORTS
• Designed in collaboration with K.O.L.’s in each specialty
• Patient data compared to normative data
METRICS
2200
7516
0
1000
2000
3000
4000
5000
6000
7000
8000
2016 2017
Analysis
Analysis
Reached 1000
analysis/month
in NOV-2017
2016 2017
Revenue
Analysis
METRICS
52000€
Analysis distribution per Platform technol
ogy
LOCAL
23%
CLOUD
77%
Analysis distribution per Business Un
it
PHARMA
39%CARE
61%
LIVER
25%
ONCO
5%
BONE
10%
CUSTOM
2%
Analysis per disease area
NEURO
15%
LUNG
42%
An exciting track record
LANZADERA acceleration program by Juan Roig 180k€
Development of the new QUIBIM platforms (MINION &
MASTER)
Customers retention
Marketing & sales strategy
2014
2015 2016QUIBIM Precision® platform v1.0
released
Booth at ECR
New customers
Seed round 550k€
First international customer (US)
Development of new algorithms
Patent application (lung emphysema)
Development of the business model
Spin-off company of IIS La Fe
2012 - 2013QUIBIM is founded by Angel Alberich-
Bayarri and Luis Martí-Bonmatí, K.O.L.’s in
image processing and radiology
First customers
2017Growth and consolidation
1.25M€ SME Instrument
ECR & RSNA booth
Filed v2.3 CE mark certification
Filed v2.3 FDA 510k certification
OUR TIMELINE
2018Partnerships with big players
ECR & RSNA booth (Machine Learning SC)
Medical Device certified
Series A for product improvement and sales
QUIBIM Care
QUIBIM Pharma
CUSTOMERS
OUR TEAM
Mª Carmen
Rodríguez
Team Coordinator
Image Analysis
Scientist
Fabio García
Castro
Ana Jiménez
Pastor
Image Analysis
Scientist
Irene Mayorga
Ruiz
Clinical Trials
Coordinator
Raúl Yébana
Huertas
Image Analysis
Technician
CTO
Rafael Hernández
Navarro
Alfredo Torregrosa
Lloret
Image Analysis
Scientist
Founder & CEO
Ángel
Alberich-Bayarri
Marketing Manager
Katherine Wilisch
Ramírez
Alejandro Mañas
García
Full Stack
Senior Developer
Belén Fos
Guarinos
Image Analysis
Scientist
COO
Encarna Sánchez
Bernabé
Chief Financial Officer
Pedro
de Álava
Management Marketing
Development
Image Analysis
Pharma
Core Lab
services
SCIENTIFIC ADVISORY BOARD
QUIBIM SL
Polytechnics and University Hospital La Fe
Av. Fernando Abril Martorell 106, Torre A, Biopolo La Fe (Valencia, Spain)
Headquarters
top related